Breast cancer has poor prognosis to be high nuclear grade, HR-negative, and HER2-positive, have a high proliferation fraction, present with lymphovascular invasion (LVI), and be diagnosed at young age and at more advanced stage10–12. This evidence concerns the gene ERBB2 and breast cancer.